Hepatitis Treatment News
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis Treatment News

October 29, 2014
Three Deaths on Olysio Lead Japan to Issue Package Warning
The deaths of three people with hepatitis C taking Olysio has led Japanese health authorities to revise the drug’s packaging to issue a safety warning.
October 27, 2014
Hep C Treatment Guidelines Re-Stress That Treatment Is for All
Hep C treatment guidelines have been revised to underline that treatment will benefit almost all HCV-positive people, regardless of disease severity. 
October 22, 2014
Core-Antigen Tests Reliably Detect Acute Hep C in People With HIV
Using hepatitis C core-antigen testing to screen for acute cases among HIV-positive people is reliable and saves resources compared with PCR testing.
October 20, 2014
Daclatasvir Cures 82% of People With Genotype 4 of Hep C
Twenty-four or 48 weeks of daclatasvir plus interferon and ribavirin cured 82 percent of people with genotype 4 of hepatitis C.
STIs and HIV Are on the Rise in London Gay Men
Gay and bisexual men in London, England, are in the middle of rising twin epidemics of HIV and sexually transmitted infections.
October 15, 2014
Coffee, Even Decaf, May Promote Liver Health
Drinking coffee, whether decaffeinated or regular, is linked to healthier levels on tests indicating liver function.
October 13, 2014
Priority for Liver Cancer Tests Should Go to Hep B-Positive Cirrhotics
People with hepatitis B and cirrhosis should be prioritized for liver cancer screening, which is cost-effective among this population.
October 08, 2014
BMS Pulls the Plug on Hep C Drug Asunaprevir in the U.S.
Bristol-Myers Squibb has decided to end its pursuit of an approval for the hepatitis C therapy asunaprevir in the United States.
October 06, 2014
Herbals and Supplements May Cause Liver Damage, Even Death
Herbals and dietary supplements (HDS) may be more dangerous to the liver than bodybuilding HDS or medications.

October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
January 2008

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Should Medicaid limit access to new hep C drugs?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.